CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,353 | -15.7% | 3,687 | +4.2% | 0.10% | -11.9% |
| Q2 2023 | $198,567 | +24.1% | 3,537 | 0.0% | 0.11% | +18.5% |
| Q1 2023 | $159,979 | +15.5% | 3,537 | +3.8% | 0.09% | +8.2% |
| Q4 2022 | $138,495 | -38.2% | 3,407 | -0.6% | 0.08% | -43.3% |
| Q3 2022 | $224,000 | +7.7% | 3,427 | 0.0% | 0.15% | +10.3% |
| Q2 2022 | $208,000 | -3.3% | 3,427 | 0.0% | 0.14% | +9.7% |
| Q1 2022 | $215,000 | +3.9% | 3,427 | +25.7% | 0.12% | +3.3% |
| Q4 2021 | $207,000 | -26.6% | 2,727 | +8.3% | 0.12% | -34.1% |
| Q3 2021 | $282,000 | +6.8% | 2,517 | +54.4% | 0.18% | -2.2% |
| Q2 2021 | $264,000 | +80.8% | 1,630 | +35.8% | 0.19% | +70.6% |
| Q1 2021 | $146,000 | – | 1,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |